]>
IRCT20230107057068N1 IRCT 2023-02-08 Arak University of Medical Sciences The effect of zinc on the blood pressure of dialysis patients The effect of zinc supplementation on blood pressure in dialysis patients 2023-02-20 anticipated 130 Complete https://irct.ir/trial/68378 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this method, first, a random sequence is created by one of the mentioned methods, then, based on the sample size of the research, a number of envelopes are prepared with aluminum foil (in order to make the content of the envelopes unclear), and each of the random sequences created is recorded on a card. The cards are placed in the letter envelopes in order. In order to preserve the random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box in order, Blinding description: In this study, the patient, researcher, care personnel and drug prescriber will be blinded. The drug and the placebo, which are already prepared and have the same shape, are distinguished from each other by A and B stickers. Then medicine A and B are distributed by health care workers who have no previous contact with the person distributing the medicine between the patients who have been randomly divided into two groups. The results of experiments and data are collected by the researcher. Only the person analyzing the information knows about drug A and B. 3 Chronic kidney disease. Intervention 1: Intervention group: 65 patients in the intervention group will receive 40 mg oral zinc supplement (Dana Pharmaceutical Company) twice a day for three months in addition to their main drugs since the beginning of the study. Intervention 2: Control group: 65 patients in the control group will also receive oral placebo capsules similar in size, shape and size to the medication in the intervention group twice a day for three months in addition to their main medications. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information.
public Azadeh Aziminejad
No.18,kosar Aven,farabi Blv,Arak
Arak Iran (Islamic Republic of) 3814331235 +98 86 3224 9783 Sina_mehra@yahoo.com Arak University of Medical Sciences scientific Azadeh Aziminejad
No.18,kosar Aven,farabi Blv,Arak
Arak Iran (Islamic Republic of) 3814331235 +98 86 3224 9783 Sina_mehra@yahoo.com Arak University of Medical Sciences Iran (Islamic Republic of) At least 3 months have passed since their dialysis Dialyses at least 2 times a week Age above 18 years 18 years no limit Both Pregnancy and breastfeeding Suffering from other chronic diseases Blood transfusion or bleeding during the study N18 Chronic kidney disease (CKD) Treatment - Drugs Treatment - Drugs Intervention group: 65 patients in the intervention group will receive 40 mg oral zinc supplement (Dana Pharmaceutical Company) twice a day for three months in addition to their main drugs since the beginning of the study. Control group: 65 patients in the control group will also receive oral placebo capsules similar in size, shape and size to the medication in the intervention group twice a day for three months in addition to their main medications. Systolic blood pressure. Timepoint: Before starting the study and twice a week for three months. Method of measurement: Using electronic pressure gauge Citizen CH 304 (Japan). ِDiastolic blood pressure. Timepoint: Before starting the study and twice a week for three months. Method of measurement: Using electronic pressure gauge Citizen CH 304 (Japan). Arak University of Medical Sciences Approved 2022-09-11 Ethics committee of Arak University of Medical Sciences Payambar azam complex, Basij Sq., Sardasht Town Arak Markazi Iran (Islamic Republic of)